Live feed
Filing
SC 13D/A
SC 13D/A0001193125-14-267819·InterWest Partners IX, LP
Schedule 13D ownership disclosure
Transcept Pharmaceuticals Inc
Security class unavailable
Event date: 2014-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-267819
- Form type
- SC 13D/A
- Filer
- InterWest Partners IX, LP
- CIK
- CIK 1398928
- Filed
- Jul 14, 2014
- Reporting period
- Jun 30, 2014
- Description
- Schedule 13D beneficial ownership